Stefanus G van Ravensteijn

6PUBLICATIONS
27CO-AUTHORS
Radiation therapyHaematological tumoursMolecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
Current clinical practice of radiotherapy for the non-operative treatment of patients with unresectable locally recurrent rectal cancer: results of a national survey of the dutch society for radiotherapy and oncology.

|Jul 09, 2025
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.

Stefan G van Ravensteijn, Jacco J de Haan, Hans Gelderblom

|Dec 12, 2024
Exploring the relation between TGF-β pathway activity and response to checkpoint inhibition in patients with metastatic melanoma.

Stefan G van Ravensteijn, Avital L Amir, Daniele V F Tauriello

|Jun 22, 2023
The Prognostic Relevance of MRI Characteristics in Myxofibrosarcoma Patients Treated with Neoadjuvant Radiotherapy.

Stefan G van Ravensteijn, Maikel J L Nederkoorn, Tom C P Wal

|Dec 11, 2022
Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.

Stefan G van Ravensteijn, Yvonne M H Versleijen-Jonkers, Melissa H S Hillebrandt-Roeffen

|May 27, 2020
Oxaliplatin infusion-related venous pain: prevention by simultaneous intravenous fluids.

Stefan van Ravensteijn, Britt van Merrienboer, Stefan van Asten

Pageof 1

Frequent Collaborators

3 joint publications

Yvonne M H Versleijen-Jonkers

2 joint publications

Mark A J Gorris

2 joint publications

Tessa J J de Bitter

1 joint publications

F E C Vande Kerckhove